Health Legislation Amendment Act 2025 (No 2) (ACT)

Case

Health Legislation Amendment Act 2025 (No 2)

A2025-33

Contents

Page

Part 1      Preliminary

1            Name of Act  2

2            Commencement  2

3            Legislation amended  2

Part 2Health Act 1993

4            Definitions—pt 6Section 80 (1), definition of approved medical facility  3

5            Declaration of protected areaSection 86 (1)  3

Part 3Health Professionals (Special Events Exemptions) Act 2000

6            Exemptions relating to offencesSection 11 (1)  4

Part 4Medicines, Poisons and Therapeutic Goods Act 2008

7           Interpretation provisions in medicines and poisons standard—application to ActSection 16 (1)  5

8            Section 16 (1), note  5

9            When authorised to deal with regulated substancesSection 20 (5), definition of recognised research institution, paragraph (c)  5

10          Section 69 (1), definition of manufacturer’s pack, note etc  5

11          Dictionary, definition of residential aged care facility  5

Part 5Medicines, Poisons and Therapeutic Goods Regulation 2008

12          Overview of things to which medicines and poisons standard does not applySection 6 (2) (a)  6

13          Section 6 (2) (b)  6

14          Section 6 (2) (c)  6

15          Section 6 (2) (d)  6

16          Section 6 (2) (e)  6

17          General overview of authorisations for medicinesSection 10 (3), note, 1st dot point  7

18          Sections 430, 431, 440 and 441  7

19          Packaging of supplied manufacturer’s packs of medicines—Act, s 59 (1) (c) (i) and (2) (c) (i)Section 501 (a)  7

20          Labelling of supplied manufacturer’s packs of medicines—Act, s 60 (1) (c) (i) and (2) (c) (i)Section 502 (2) (a)  7

21          Packaging of supplied manufacturer’s packs of low and moderate harm poisons—Act, s 59 (1) (c) (i) and (2) (c) (i)Section 665 (1) (a)  7

22          Labelling of supplied manufacturer’s packs of low and moderate harm poisons—Act, s 60 (1) (c) (i) and (2) (c) (i)Section 666 (a)  8

23          General overview of authorisations for dangerous poisonsSection 670 (3), note, 1st dot point  8

24          Authorisation conditions for dangerous poisons suppliers licences—Act, s 44 (1) (b) and (2) (b)Section 686 (d) and note  8

25          Recording supply of dangerous poisonsSection 722  8

26          Packaging of supplied manufacturer’s packs of dangerous poisons—Act, s 59 (1) (c) (i) and (2) (c) (i)Section 731 (a)  8

27          Labelling of supplied manufacturer’s packs of dangerous poisons—Act, s 60 (1) (c) (i) and (2) (c) (i)Section 732 (a)  9

28          Storage of dangerous poisons—Act, s 61 (b) and (c)Section 735 (2)  9

29          Section 751 heading  9

30          Section 751 (2)  9

31          Section 752  9

32          Manufacture, supply and use of paints containing pesticides—Act, s 73 (b)Section 753 (1)  10

33          Section 862  10

34          Dictionary, definition of primary pack and note  10

35          Further amendments, notes  10

36          Further amendments, mentions of (Drugs required to be labelled with a sedation warning)      11

Part 6Voluntary Assisted Dying Act 2024

37          Notifying individual and board about outcome of final assessmentSection 36 (2)  12

38          Section 36 (4) (a)  12

39          Transfer request made by individualNew section 38 (5) (aa)  12

40          Section 41  13

41          Transfer of administering practitioner functions—transfer request made by individualNew section 47 (5) (ba)  13

42          Giving, receiving and possessing approved substances—change in contact personSection 67 (5) (a) and (b) (ii)  13

43          Contact person to tell coordinating practitioner about deathSection 78 (2)  14

44          Definitions—pt 7Section 101 (1), definition of facility, paragraph (d)  14

45          Section 101 (1), definition of resident, examples  14

46          Section 101 (2), definitions of residential aged care facility and residential care 14

47          Requirements for health professionals when raising voluntary assisted dying as an end of life choiceSection 155 (1)  15

48          Section 155 (1) (b)  15

49          Section 155 (3)  15

Health Legislation Amendment Act 2025 (No 2)

A2025-33

An Act to amend legislation about health

The Legislative Assembly for the Australian Capital Territory enacts as follows:

Part 1Preliminary

  1. Name of Act

    This Act is the Health Legislation Amendment Act 2025 (No 2).

  2. Commencement

    (1)Sections 11 and 44 to 46 commence on the later of—

    (a)the 14th day after this Act’s notification day; and

    (b)the commencement of the Aged Care Act 2024 (Cwlth), section 10.

    NoteThe naming and commencement provisions automatically commence on the notification day (see Legislation Act, s 75 (1)).

    (2)Part 6 (other than sections 44 to 46) commences on the later of—

    (a)the day after this Act’s notification day; and

    (b)the commencement of the Voluntary Assisted Dying Act 2024, section 3.

    (3)The remaining provisions commence on the 14th day after this Act’s notification day.

  3. Legislation amended

    This Act amends the following legislation:

    ·Health Act 1993

    ·Health Professionals (Special Events Exemptions) Act 2000

    ·Medicines, Poisons and Therapeutic Goods Act 2008

    ·Medicines, Poisons and Therapeutic Goods Regulation 2008

    ·Voluntary Assisted Dying Act 2024.

Part 2Health Act 1993

  1. Definitions—pt 6
    Section 80 (1), definition of approved medical facility

    after

    a medical facility

    insert

    , or a part of a medical facility,

  2. Declaration of protected area
    Section 86 (1)

    substitute

    (1)The Minister must, on application by a person responsible for the management of an approved medical facility, declare an area around the facility to be a protected area.

Part 3Health Professionals (Special Events Exemptions) Act 2000

  1. Exemptions relating to offences
    Section 11 (1)

    omit

    Skin Penetration Procedures Act 1994

    substitute

    Public Health Act 1997, part 3

Part 4Medicines, Poisons and Therapeutic Goods Act 2008

  1. Interpretation provisions in medicines and poisons standard—application to Act
    Section 16 (1)

    omit

    (other than the definition of poison)

  2. Section 16 (1), note

    omit

  3. When authorised to deal with regulated substances
    Section 20 (5), definition of recognised research institution, paragraph (c)

    substitute

    (c)a hospital operated by the Territory;

  4. Section 69 (1), definition of manufacturer’s pack, note etc

    omit the following notes

    ·     section 69 (1), definition of manufacturer’s pack, note

    ·     division 4.3.6 heading, note

    ·     section 71 (1) to (3), notes

    ·     section 73, note

  5. Dictionary, definition of residential aged care facility

    substitute

    residential aged care facility means a residential care home within the meaning of the Aged Care Act 2024 (Cwlth), section 10.

Part 5Medicines, Poisons and Therapeutic Goods Regulation 2008

  1. Overview of things to which medicines and poisons standard does not apply
    Section 6 (2) (a)

    omit

    (General Exemptions) (see the standard, par 1 (2) (h))

  2. Section 6 (2) (b)

    omit

    (Substances considered not to require control by scheduling) (see the standard, par 1 (2) (h))

  3. Section 6 (2) (c)

    substitute

    (c)a substance to which the standard, appendix G applies;

  4. Section 6 (2) (d)

    omit

    (see the standard, par 1 (2) (j))

  5. Section 6 (2) (e)

    omit

    (see the standard, par 1 (2) (k))

  6. General overview of authorisations for medicines
    Section 10 (3), note, 1st dot point

    omit

    , par 1 (2) (see s 6)

  7. Sections 430, 431, 440 and 441

    omit

    the Canberra Hospital

    substitute

    a hospital operated by the Territory

  8. Packaging of supplied manufacturer’s packs of medicines—Act, s 59 (1) (c) (i) and (2) (c) (i)
    Section 501 (a)

    omit

    , sections 2.1 (2) to 2.6 (2)

  9. Labelling of supplied manufacturer’s packs of medicines—Act, s 60 (1) (c) (i) and (2) (c) (i)
    Section 502 (2) (a)

    omit

    , sections 1.1 (2) to 1.6 (2)

  10. Packaging of supplied manufacturer’s packs of low and moderate harm poisons—Act, s 59 (1) (c) (i) and (2) (c) (i)
    Section 665 (1) (a)

    omit

    , sections 2.1 (2) to 2.6 (2)

  11. Labelling of supplied manufacturer’s packs of low and moderate harm poisons—Act, s 60 (1) (c) (i) and (2) (c) (i)
    Section 666 (a)

    omit

    , sections 1.1 (2) to 1.6 (2)

  12. General overview of authorisations for dangerous poisons
    Section 670 (3), note, 1st dot point

    omit

    , par 1 (2) (see s 6)

  13. Authorisation conditions for dangerous poisons suppliers licences—Act, s 44 (1) (b) and (2) (b)
    Section 686 (d) and note

    substitute

    (d)if a dangerous poison sold under the licence is subject to the medicines and poisons standard, appendix J—the poison will be supplied only to a person who is allowed to use the poison under the appendix;

  14. Recording supply of dangerous poisons
    Section 722

    omit

    , section 5.1 (1) and (2)

  15. Packaging of supplied manufacturer’s packs of dangerous poisons—Act, s 59 (1) (c) (i) and (2) (c) (i)
    Section 731 (a)

    omit

    , sections 2.1 (2) to 2.6 (2)

  16. Labelling of supplied manufacturer’s packs of dangerous poisons—Act, s 60 (1) (c) (i) and (2) (c) (i)
    Section 732 (a)

    omit

    , sections 1.1 (2) to 1.6 (2)

  17. Storage of dangerous poisons—Act, s 61 (b) and (c)
    Section 735 (2)

    omit

    , section 3.1 (1) and (2)

  18. Section 751 heading

    substitute

  19. Manufacture, supply and use of first group paints for certain purposes—Act, s 71 (1)

  20. Section 751 (2)

    omit

  21. Section 752

    substitute

751AManufacture, supply and use of paints or tinters for certain purposes—Act, s 71 (3)

A paint or tinter is prescribed if it must not be manufactured, supplied or used under the medicines and poisons standard if it contains more than a stated amount of lead.

  1. Manufacture, supply and use of paints for toys—Act, s 72 (b)

    A paint that complies with the requirements for paints for application to toys under the medicines and poisons standard is prescribed.

  2. Manufacture, supply and use of paints containing pesticides—Act, s 73 (b)
    Section 753 (1)

    substitute

    (1)A pesticide is prescribed if a paint or tinter containing the pesticide may be manufactured, supplied or used under the medicines and poisons standard.

  3. Section 862

    substitute

  4. Certain containers not to be used for human-use substances—Act, s 63 (1) (b)

    A container that must not be used to supply a human-use product under the medicines and poisons standard is prescribed.

  5. Dictionary, definition of primary pack and note

    omit

  6. Further amendments, notes

    omit the following notes

    ·section 72 (e), note

    ·section 76 (f), note

    ·section 78 (f), note

    ·section 123 (f), note

    ·section 125 (h), note

    ·section 132 (a), note

    ·section 141 (2) (a), note

    ·section 161 (d), note

    ·section 162 (b), note

    ·section 253 (e), note

    ·section 256 (e), note

    ·section 751 (1) (d), note

    ·dictionary, definition of manufacturer’s pack, note

  7. Further amendments, mentions of (Drugs required to be labelled with a sedation warning)

    omit

    (Drugs required to be labelled with a sedation warning)

    in

    ·section 123 (m)

    ·section 152 (f)

    ·section 161 (g)

    ·section 253 (h)

    ·section 256 (i)

Part 6Voluntary Assisted Dying Act 2024

  1. Notifying individual and board about outcome of final assessment
    Section 36 (2)

    omit

    If the coordinating practitioner decides that

    substitute

    After the coordinating practitioner decides whether

  2. Section 36 (4) (a)

    omit

    that

    substitute

    whether

  3. Transfer request made by individual
    New section 38 (5) (aa)

    insert

    (aa)record the request acceptance in the individual’s health record; and

  4. Section 41

    substitute

  5. Application—div 4.1

    This division applies if an individual’s coordinating practitioner has—

    (a)decided that the individual meets the final assessment requirements; and

    (b)prepared a final assessment report for the individual.

  6. Transfer of administering practitioner functions—transfer request made by individual
    New section 47 (5) (ba)

    insert

    (ba)record the request acceptance in the individual’s health record; and

  7. Giving, receiving and possessing approved substances—change in contact person
    Section 67 (5) (a) and (b) (ii)

    after

    given the substance to

    insert

    the individual or

  8. Contact person to tell coordinating practitioner about death
    Section 78 (2)

    omit

    2 business days

    substitute

    4 business days

  9. Definitions—pt 7
    Section 101 (1), definition of facility, paragraph (d)

    substitute

    (d)a residential care home within the meaning of the Aged Care Act 2024 (Cwlth), section 10.

  10. Section 101 (1), definition of resident, examples

    omit

    residential aged care facility

    substitute

    residential care home

  11. Section 101 (2), definitions of residential aged care facility and residential care

    omit

  12. Requirements for health professionals when raising voluntary assisted dying as an end of life choice
    Section 155 (1)

    after

    A doctor or nurse practitioner

    insert

    with the necessary expertise

  13. Section 155 (1) (b)

    omit

  14. Section 155 (3)

    substitute

    (3)In this section:

    necessary expertise—a doctor or nurse practitioner has the necessary expertise if they are satisfied that they have the expertise to appropriately discuss treatment and palliative care options with an individual.

    relevant health professional means—

    (a)a counsellor who meets the requirements prescribed by regulation; or

    (b)a health practitioner other than a doctor or nurse practitioner with the necessary expertise; or

    (c)a social worker who meets the requirements prescribed by regulation; or

    (d)any other health professional prescribed by regulation.

Endnotes

  1. Presentation speech

    Presentation speech made in the Legislative Assembly on 4 September 2025.

  2. Notification

    Notified under the Legislation Act on 12 November 2025.

  3. Republications of amended laws

    For the latest republication of amended laws, see certify that the above is a true copy of the Health Legislation Amendment Bill 2025 (No 2), which was passed by the Legislative Assembly on 30 October 2025.

    Clerk of the Legislative Assembly

    © Australian Capital Territory 2025

Actions
Download as PDF Download as Word Document
Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0